The Ministry of Health, through the National Institute of Health Management (Ingesa), has awarded the first Framework Agreement for the acquisition of a total of 81 linear accelerators included in the High Technology Equipment Investment Plan (Inveat) for a total of 212,761,357.81 euros.
This Framework Agreement, the first of the eight that INGESA is processing for the development of the Inveat Plan, will entail the acquisition of high-tech equipment for the treatment of oncological diseases by a total of 15 autonomous communitiesin addition to the Ministry of Defense.
Specifically, it includes three lots focused on the acquisition of high-performance linear accelerators; high energy linear accelerators for adaptive radiotherapy; and linear accelerators for radiosurgery treatments and extracranial stereotactic radiotherapy (SBRT), a high-precision irradiation technique that allows irradiation of lesions located outside the skull with ablative doses.
The companies that have been awarded are Ab Salud, Elekta Medica and Varian Medical Systems Ibérica.
In addition, the Ingesa has already begun the processing of the remaining seven Framework Agreementswhich will facilitate the acquisition of interventional cardiology equipment (Hemodynamics), Interventional Vascular and Interventional Neurovascular Radiology equipment, Computed Tomography equipment, Digital Brachytherapy equipment, Magnetic Resonance Imaging (MRI) equipment, PET-CT equipment, and SPECT-CT.
It should be remembered that the Inveat Plan foresees an investment of more than 795 million euros over the next two years throughout Spainand will allow the renewal of 585 pieces of equipment in the technological park of the National Health System and the expansion of another 262. In total, the renewal or expansion of 847 pieces of equipment throughout the country will be facilitated.